January 29, 2015 3:27 AM ET


Company Overview of Introgen Therapeutics Inc.

Company Overview

On May 17, 2010, Introgen Therapeutics Inc. went out of business as per its Chapter 11 liquidation filing under bankruptcy. Introgen Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of targeted molecular therapies for the treatment of cancer and other diseases. The company is developing product candidates to treat a range of cancers using tumor suppressors, cytokines, and other targeted molecular therapies. Its lead product candidate include ADVEXIN therapy, which combines the p53 tumor suppressor with a non-replicating, non-integrating, and adenoviral delivery system. ADVEXIN therapy is in Phase III clinical trials in patients wit...

8066 El Rio

Houston, TX 77054

United States

Founded in 1993

80 Employees





Key Executives for Introgen Therapeutics Inc.

Introgen Therapeutics Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Ercole Biotech, Inc. United States
XBiotech USA, Inc. United States
PDS Biotechnology Corporation United States
Aveva Drug Delivery Systems, Inc. United States
Revimmune, Inc United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Introgen Therapeutics Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.